Truist Financial Corp Gsk PLC Transaction History

Truist Financial Corp

$62.9 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$42.05 - $47.77 $620,994 - $705,467	-14,768 Reduced 4.66%	301,954 $13.1 Million
Q1 2022 Apr 22, 2022	BUY	$40.23 - $47.74 $71,528 - $84,881	1,778 Added 0.56%	316,722 $13.8 Million
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $342,455 - $399,090	8,808 Added 2.88%	314,944 $13.9 Million
Q3 2021 Nov 05, 2021	BUY	$38.79 - $43.16 $1.73 Million - $1.92 Million	44,592 Added 17.05%	306,136 $11.7 Million
Q2 2021 Aug 16, 2021	BUY	$36.52 - $41.46 $1.03 Million - $1.17 Million	28,310 Added 12.14%	261,544 $10.4 Million
Q1 2021 May 17, 2021	SELL	$34.27 - $40.01 $4.07 Million - $4.75 Million	-118,838 Reduced 33.75%	233,234 $8.32 Million
Q4 2020 Feb 18, 2021	SELL	$34.07 - $39.94 $13.5 Million - $15.8 Million	-395,680 Reduced 52.92%	352,072 $13 Million
Q3 2020 Nov 05, 2021	BUY	$38.11 - $42.99 $43,178 - $48,707	1,133 Added 0.15%	747,752 $28.1 Million
Q3 2020 Nov 13, 2020	SELL	$38.11 - $42.99 $3.63 Million - $4.1 Million	-95,307 Reduced 11.32%	746,619 $28.1 Million
Q2 2020 Nov 16, 2021	BUY	$37.87 - $43.58 $42,906 - $49,376	1,133 Added 0.13%	841,926 $34.3 Million
Q2 2020 Aug 14, 2020	SELL	$37.87 - $43.58 $3.72 Million - $4.28 Million	-98,232 Reduced 10.46%	840,793 $34.3 Million
Q1 2020 Nov 05, 2021	BUY	$32.47 - $48.83 $36,788 - $55,324	1,133 Added 0.12%	939,025 $35.6 Million
Q1 2020 May 15, 2020	SELL	$32.47 - $48.83 $2.45 Million - $3.68 Million	-75,437 Reduced 7.44%	937,892 $35.5 Million
Q4 2019 Nov 16, 2021	BUY	$42.0 - $48.25 $47,586 - $54,667	1,133 Added 0.11%	1,013,329 $47.6 Million
Q4 2019 Feb 14, 2020	BUY	$42.0 - $48.25 $35.3 Million - $40.5 Million	839,645 Added 486.61%	1,012,196 $47.6 Million
Q3 2019 Oct 31, 2019	SELL	$40.46 - $43.52 $32,570 - $35,033	-805 Reduced 0.46%	172,551 $7.37 Million
Q2 2019 Jul 24, 2019	SELL	$39.4 - $42.7 $147,474 - $159,826	-3,743 Reduced 2.11%	173,356 $6.94 Million
Q1 2019 Apr 23, 2019	SELL	$38.57 - $42.69 $319,436 - $353,558	-8,282 Reduced 4.47%	177,099 $7.4 Million
Q4 2018 Jan 22, 2019	SELL	$37.8 - $42.69 $782,800 - $884,067	-20,709 Reduced 10.05%	185,381 $7.08 Million
Q3 2018 Oct 17, 2018	SELL	$39.75 - $42.69 $320,901 - $344,636	-8,073 Reduced 3.77%	206,090 $8.28 Million
Q2 2018 Jul 26, 2018	BUY	$39.61 - $42.76 $309,076 - $333,656	7,803 Added 3.78%	214,163 $8.63 Million
Q1 2018 Apr 20, 2018	BUY	$36.18 - $40.15 $749,143 - $831,345	20,706 Added 11.15%	206,360 $8.06 Million
Q4 2017 Jan 29, 2018	SELL	$35.34 - $41.9 $717,790 - $851,030	-20,311 Reduced 9.86%	185,654 $6.59 Million
Q3 2017 Oct 23, 2017	BUY	$39.44 - $41.55 $8.12 Million - $8.56 Million	205,965	205,965 $8.36 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account